185 related articles for article (PubMed ID: 36668840)
1. Prediction Model for Identifying Computational Phenotypes of Children with Cerebral Palsy Needing Neurotoxin Treatments.
Bertoncelli CM; Latalski M; Bertoncelli D; Bagui S; Bagui SC; Gautier D; Solla F
Toxins (Basel); 2022 Dec; 15(1):. PubMed ID: 36668840
[TBL] [Abstract][Full Text] [Related]
2. PredictMed-epilepsy: A multi-agent based system for epilepsy detection and prediction in neuropediatrics.
Bertoncelli CM; Costantini S; Persia F; Bertoncelli D; D'Auria D
Comput Methods Programs Biomed; 2023 Jun; 236():107548. PubMed ID: 37149974
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of botulinum toxin A for upper and lower limb spasticity in children with cerebral palsy: a summary of evidence.
Lukban MB; Rosales RL; Dressler D
J Neural Transm (Vienna); 2009 Mar; 116(3):319-31. PubMed ID: 19142573
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of spasticity in children with cerebral palsy with botulinum toxin A].
Madsen ES; Sonne-Holm S; Wong C; Curtis D; Bencke J
Ugeskr Laeger; 2015 Jan; 177(3):V07140409. PubMed ID: 25613095
[TBL] [Abstract][Full Text] [Related]
5. The effect of botulinum toxin A (Botox) injections used to treat limb spasticity on speech patterns in children with dysarthria and cerebral palsy: A report of two cases.
Workinger MS; Kent RD; Meilahn JR
J Pediatr Rehabil Med; 2017 May; 10(2):137-143. PubMed ID: 28582880
[TBL] [Abstract][Full Text] [Related]
6. Safety profile of incobotulinum toxin A [Xeomin(®)] in gastrocnemious muscles injections in children with cerebral palsy: Randomized double-blind clinical trial.
Carraro E; Trevisi E; Martinuzzi A
Eur J Paediatr Neurol; 2016 Jul; 20(4):532-7. PubMed ID: 27177451
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of multiple botulinum toxin sessions and the duration of effects in spasticity therapy in children with cerebral palsy.
Mirska A; Kułak W; Okurowska-Zawada B; Dmitruk E
Childs Nerv Syst; 2019 Jan; 35(1):141-147. PubMed ID: 30058050
[TBL] [Abstract][Full Text] [Related]
8. Use of botulinum toxin A in management of children with cerebral palsy.
Friedman BC; Goldman RD
Can Fam Physician; 2011 Sep; 57(9):1006-73. PubMed ID: 21918142
[TBL] [Abstract][Full Text] [Related]
9. Combining strength training and botulinum neurotoxin intervention in children with cerebral palsy: the impact on muscle morphology and strength.
Williams SA; Elliott C; Valentine J; Gubbay A; Shipman P; Reid S
Disabil Rehabil; 2013 Apr; 35(7):596-605. PubMed ID: 22928803
[TBL] [Abstract][Full Text] [Related]
10. Identifying Postural Instability in Children with Cerebral Palsy Using a Predictive Model: A Longitudinal Multicenter Study.
Bertoncelli CM; Bertoncelli D; Bagui SS; Bagui SC; Costantini S; Solla F
Diagnostics (Basel); 2023 Jun; 13(12):. PubMed ID: 37371021
[TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy.
Wasiak J; Hoare B; Wallen M
Cochrane Database Syst Rev; 2004 Oct; (4):CD003469. PubMed ID: 15495055
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of abobotulinumtoxinA for upper limb spasticity in children with cerebral palsy: a randomized repeat-treatment study.
Delgado MR; Tilton A; Carranza-Del Río J; Dursun N; Bonikowski M; Aydin R; Maciag-Tymecka I; Oleszek J; Dabrowski E; Grandoulier AS; Picaut P;
Dev Med Child Neurol; 2021 May; 63(5):592-600. PubMed ID: 33206382
[TBL] [Abstract][Full Text] [Related]
13. Quantitative evaluation for spasticity of calf muscle after botulinum toxin injection in patients with cerebral palsy: a pilot study.
Lin YC; Lin IL; Chou TF; Lee HM
J Neuroeng Rehabil; 2016 Mar; 13():25. PubMed ID: 26969526
[TBL] [Abstract][Full Text] [Related]
14. Is an instrumented spasticity assessment an improvement over clinical spasticity scales in assessing and predicting the response to integrated botulinum toxin type a treatment in children with cerebral palsy?
Bar-On L; Van Campenhout A; Desloovere K; Aertbeliën E; Huenaerts C; Vandendoorent B; Nieuwenhuys A; Molenaers G
Arch Phys Med Rehabil; 2014 Mar; 95(3):515-23. PubMed ID: 23994052
[TBL] [Abstract][Full Text] [Related]
15. A French observational study of botulinum toxin use in the management of children with cerebral palsy: BOTULOSCOPE.
Chaléat-Valayer E; Parratte B; Colin C; Denis A; Oudin S; Bérard C; Bernard JC; Bourg V; Deleplanque B; Dulieu I; Evrard P; Filipetti P; Flurin V; Gallien P; Héron-Long B; Hodgkinson I; Husson I; Jaisson-Hot I; Maupas E; Meurin F; Monnier G; Pérennou D; Pialoux B; Quentin V; Moreau MS; Schneider M; Yelnik A; Marque P
Eur J Paediatr Neurol; 2011 Sep; 15(5):439-48. PubMed ID: 21745754
[TBL] [Abstract][Full Text] [Related]
16. Treatment with Botulinum toxin A in a total population of children with cerebral palsy - a retrospective cohort registry study.
Franzén M; Hägglund G; Alriksson-Schmidt A
BMC Musculoskelet Disord; 2017 Dec; 18(1):520. PubMed ID: 29228927
[TBL] [Abstract][Full Text] [Related]
17. [Botulinum toxin type A for the treatment of spasticity in children with cerebral palsy].
Dimitrijević L; Stanković I; Zivković V; Mikov A; Colović H; Janković I
Vojnosanit Pregl; 2007 Aug; 64(8):513-8. PubMed ID: 17874717
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin treatment in cerebral palsy: evidence for a new treatment option.
Kirschner J; Berweck S; Mall V; Korinthenberg R; Heinen F
J Neurol; 2001 Apr; 248 Suppl 1():28-30. PubMed ID: 11357236
[TBL] [Abstract][Full Text] [Related]
19. Plasma Metabolomic Changes in Children with Cerebral Palsy Exposed to Botulinum Neurotoxin.
Tang H; Peng T; Yang X; Liu L; Xu Y; Zhao Y; Huang S; Fu C; Huang Y; Zhou H; Li J; He L; Wang W; Niu H; Xu K
J Proteome Res; 2022 Mar; 21(3):671-682. PubMed ID: 35018779
[TBL] [Abstract][Full Text] [Related]
20. [Effectiveness of botulinum toxin in diminishing lower limbs spasticity in children with diplegic form of cerebral palsy].
Gugała B; Snela S
Chir Narzadow Ruchu Ortop Pol; 2011; 76(2):91-5. PubMed ID: 21853909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
